Velan Capital Investment Management’s Gossamer Bio GOSS Stock Holding History

Velan Capital Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.5K	Hold	875	–	–	0.01%	51
2026 Q1	$23K	Hold	875	–	–	0.01%	49
2025 Q4	$217K	Hold	875	–	–	0.13%	34
2025 Q3	$184K	Sell	875 -63	-7%	-$11.1K	0.17%	31
2025 Q2	$92.3K	Hold	938	–	–	0.09%	35
2025 Q1	$82.5K	Hold	938	–	–	0.08%	31
2024 Q4	$67.8K	Buy	+938	New	+$64.3K	0.06%	32
2023 Q4	–	Sell	-38,314	Closed	-$2.55M	–	25
2023 Q3	$2.55M	Buy	+38,314	New	+$3.53M	2.06%	14

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Velan Capital Investment Management's GOSS Position: Q2 2026 in Review

Velan Capital Investment Management held its Gossamer Bio (GOSS) position steady in Q2 2026 at 875 shares worth $11.5K. The position accounts for 0.01% of the portfolio, ranked #51.

Velan Capital Investment Management first reported a position in GOSS in Q3 2023 and has held it in 8 quarters since. The position peaked at $2.55M in Q3 2023. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Velan Capital Investment Management held 875 shares of Gossamer Bio worth $11.5K as of Q2 2026.
Velan Capital Investment Management left its Gossamer Bio share count unchanged in Q2 2026.
Gossamer Bio made up 0.01% of Velan Capital Investment Management's portfolio in Q2 2026, its #51 holding.
Velan Capital Investment Management first reported a position in Gossamer Bio in Q3 2023 and has held it in 8 quarters since.
Velan Capital Investment Management's Gossamer Bio position peaked at $2.55M in Q3 2023.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.